Evidence map›Paper›PMID 37882457›Full record

ArticleNeuropsychopharmacology reports2024

Reducing the use of psychotropics in a convalescent rehabilitation ward.

Takuya Uematsu, Takashi Tomita, Ryo Obara, Takuya Gonai, Koshi Hattori, Takanori Aonuma, Kensuke Usui, Hiroaki Tanifuji, Fumiaki Ishizawa, Hiroshi Ishii and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neuropsychopharmacology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Takuya UematsuDepartment of Pharmacy, Kawasaki Kokoro Hospital, Kawasaki, Japan.ORCID https://orcid.org/0009-0003-9724-4844
Takashi TomitaDepartment of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare, Otawara, Japan.
Ryo ObaraDepartment of Pharmacy, Kawasaki Kokoro Hospital, Kawasaki, Japan.ORCID https://orcid.org/0000-0003-1022-3569
Takuya GonaiDepartment of Pharmacy, Kawasaki Kokoro Hospital, Kawasaki, Japan.ORCID https://orcid.org/0009-0007-2066-7290
Koshi HattoriDepartment of Rehabilitation, Tohoku University Hospital, Sendai, Japan.
Takanori AonumaDepartment of Rehabilitation, Kawasaki Kokoro Hospital, Kawasaki, Japan.
Kensuke UsuiDivision of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University, Sendai, Japan.ORCID https://orcid.org/0000-0002-5318-8882
Hiroaki TanifujiDepartment of Pharmacy, Kodama Hospital, Ishinomaki, Japan.
Fumiaki IshizawaDepartment of Pharmacy, Kawasaki Kokoro Hospital, Kawasaki, Japan.
Hiroshi IshiiGeriatric Psychiatry, Kawasaki Kokoro Hospital, Kawasaki, Japan.
Eiji SuzukiDivision of Psychiatry, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kawasaki Hospital · JPTohoku Medical and Pharmaceutical University · JPKoto Hospital · JPMita Hospital · JPTohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsMany patients who are transferred to the convalescent rehabilitation ward of Kawasaki Kokoro Hospital (hereinafter, our hospital) are on psychotropics prescribed for delirium by their physicians at acute care hospitals. In this study, psychiatrists and pharmacists collaborated with rehabilitation physicians to reduce the use of psychotropics.

methodsThe basic information and psychotropics prescription statuses of 88 patients discharged from the convalescent rehabilitation ward of our hospital between April 1, 2021 and March 31, 2022 were derived from their medical records.

resultsAt admission, psychotropics were prescribed to 55 patients and the number of prescribed drugs was 2 (median). At discharge, psychotropics were prescribed to 41 patients and the number of prescribed drugs was 1 (median), showing a significant decrease (p < 0.05). Compared with those at admission, prescribed psychotropic doses at discharge were significantly higher for lemborexant but significantly lower for antipsychotics, benzodiazepine/nonbenzodiazepine hypnotics, antidepressants, suvorexant, ramelteon, and sodium valproate (p < 0.05).

conclusionsThese results suggest that it may be possible to reduce the types and doses of psychotropics prescribed at acute care hospitals in convalescent rehabilitation wards. However, further investigation is needed because the number of patients in this study was limited, and selection bias due to different patient characteristics cannot be ruled out.

Indexed as

Antipsychotic AgentsPsychotropic DrugsAntidepressive AgentsHospitalsHumansPatient DischargeAntidepressive AgentsAntipsychotic AgentsPsychotropic Drugsconvalescent rehabilitation warddeliriumolder adult patientspolypharmacypsychotropics

Identifiers

PMID37882457
PMCPMC10932766
OpenAlexW4387948780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.